NCT07675044Not yet recruiting
Quantifying the Burden of Type 2 (T2) Inflammation in Asthma
QUANTAS-PC: Quantifying the Burden of Type 2 (T2) Inflammation in Asthma in Primary Care and Community Specialty Practices
Source: ClinicalTrials.gov · Last updated 30 Jun 2026
Brief summary (registry, in English)
This study is designed to support the assessment of Type 2 (T2) biomarkers in asthma in primary care and community specialty practices. To assess T2 biomarkers, individuals will be required to complete a breath test for fractional exhaled nitric oxide (FeNO) and consent to a review of their medical records. Asthma often goes undetected in primary care and community settings, and through this study the researchers hope to optimize referral pathways to care.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 23 Jun 2026
- Start date
- Jul 2026
- Primary completion date
- May 2027
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Diseases
- Asthma
- NCT number
- NCT07675044
What you commit to
- Study type: Observational
- Planned participants: 200
- From Jul 2026 to the primary completion date, May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Participant Inclusion Criteria
- Age 18 years and older
- Ability to consent and comply with protocol assessments
- Pre-existing diagnosis of asthma and has started treatment
- Participant Exclusion Criteria
- Participant deemed medically ineligible per the opinion of the investigator
- History of respiratory/lung disease other than asthma (e.g., COPD, emphysema, chronic bronchitis, tuberculosis, cystic fibrosis, lung cancer, recurrent pneumonia or other chronic lung disease)
- Participants who meet criteria for GINA 5, severe asthma (ICS + additional controllers)
- Current Enrollment in an asthma intervention trial that could affect asthma outcomes clinically and T2 biomarkers
- Visit with a specialist (i.e. Pulmonologist or Allergist) in the past year who is measuring FeNO levels
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mount Sinai Health System Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.